Anzeige
Meldung des Tages: Auftakt zu Maßnahmen: Grundlegendes Material für die Verteidigungsindustrie der USA wird immer wichtiger

Ipsen Aktie News

Aktie
WKN:  A0ESMG ISIN:  FR0010259150 US-Symbol:  IPSEF Branche:  Pharmazeutika Land:  Frankreich
136,20 €
-1,10 €
-0,80%
08:01:26 Uhr
Depot/Watchlist
Marktkapitalisierung *
10,01 Mrd. €
Streubesitz
27,41%
KGV
26,60
Dividende
1,40 €
Dividendenrendite
1,18%
neu: Nachhaltigkeits-Score
68 %
Index-Zuordnung
-

Ipsen News

06.05.25 - GlobeNewswire
Ipsen appoints Laura Réveillon as EVP, Strategy & Transformation
PARIS, FRANCE, 06 May 2025 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty care-​driven biopharmaceutical company, announced today the appointment of Laura Réveillon, ...
24.04.25 - GlobeNewswire
Late-breaking elafibranor primary sclerosing cholangitis (PSC) data demonstrates favorable safety profile and significant efficacy in second potential rare liver disease indication
Elafibranor showed a favorable safety profile and demonstrated dose-​dependent efficacy over 12 weeks for people living with PSC, a rare liver disease that currently has no ...
16.04.25 - GlobeNewswire
Ipsen delivers strong sales in the first quarter 2025 and confirms its full-year guidance
Total sales growth of 11.6% at CER 1 , or 11.7% as reported, driven by all three therapeutic areas and including an increasing contribution from Iqirvo and Bylvay. Tovorafenib ...
19.03.25 - GlobeNewswire
Ipsen announces issuance of €500 million inaugural Rated Public Bond
Transaction follows Investment Grade ratings assignment from both S&P and Moody’s
12.03.25 - GlobeNewswire
Ipsen appoints Olivia Brown as Executive Vice-President, Global Head of Neurotoxins
PARIS, FRANCE, March 12 th , 2025 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty care-​driven company, announced today the appointment of Olivia Brown as, EVP, Global ...
13.02.25 - GlobeNewswire
Ipsen delivers solid results in 2024, driven by strong performance across all therapeutic areas, and provides guidance for 2025
FY 2024 total sales growth of 9.9% at CER 1 , or 8.7% as reported, with growth driven by strong performance across all therapeutic areas, including a 67.4% increase in the Rare ...

Newssuche

Videos

newspaper
12:40 Uhr +27,72%
Technical Trading Silber Crash!
Silber Short Typ: Turbo Open End WKN: VJ4GQU Hebel: 3,77 Laufzeit: OpenEnd Einstieg: Market ... Mehr »